Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sun Pharma Share Price Live Updates: Average trading volume insights
Sun Pharma Share Price Live Updates: Sun Pharma's Stock Shows Positive Momentum
Indices trade with significant cuts; pharma share advance for 3rd day
At 14:28 IST, the barometer index, the S&P BSE Sensex advanced 403.55 points or 0.53% to 77,206.46. The Nifty 50 index rose 118.05 points or 0.50% to 24,132.45.
Sun Pharma to acquire 100% stake in Innovcare Lifesciences for Rs 271 crore
Sun Pharmaceutical Industries said that it has entered into an agreement for acquiring 100% outstanding shares of Innovcare Lifesciences for a total consideration of Rs 271.2 crore.
Stock Alert: Sun Pharma, GRSE, GE Power, Goodluck India, Zaggle Prepaid, Texmaco Rail - Business Standard
Stock Alert: Sun Pharma, GRSE, GE Power, Goodluck India, Zaggle Prepaid, Texmaco RailBusiness Standard
Stocks to Watch today: RIL, RVNL, Voltas, Sun Pharma, TaMo, Bharat Forge
Stocks to Watch today: RIL, RVNL, Voltas, Sun Pharma, TaMo, Bharat Forge, Dalmia Bharat are among other stocks that will be in focus today.
Stocks to watch: Sun Pharma, Nestle India, Bharat Forge among shares in focus today; check list here
Stock market today: On Friday, the Sensex fell 607.08 points, or 0.78%, to finish at 76,802.90, while the Nifty 50 slipped 154.90 points, or 0.64%, to settle at 24,013.10.
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGC
Indian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despite this, the broader recovery trend remains intact above 23,700. Several companies like Sun Pharma, Tata Motors, and ONGC are in focus due to significant business developments, including acquisitions, order wins, and strategic repositioning.
Sun Pharma to acquire Innovcare Lifesciences for ₹271.2 crore
Acquisition of the Mumbai-based pharma, nutraceutical and cosmeceutical products company is aimed at strengthening Sun Pharma’s product portfolio.
Sun Pharma To Acquire 100% Share In Invocare Lifesciences For Rs 271 Crore
Sun Pharma described the acquisition as a strategic investment to strengthen its product portfolio.
Sun Pharma adds Innovcare to its fold in Rs 271.2 crore all-cash transaction
India's largest drugmaker, Sun Pharma, is set to acquire Mumbai-based Innovcare Lifesciences for approximately $28.7 million in an all-cash deal. This strategic move aims to bolster Sun Pharma's product offerings. Innovcare, which markets pharmaceutical drugs, nutraceuticals, and cosmeceuticals, reported steady revenue growth in recent fiscal years. The transaction, expected to conclude by July 2026, is a significant step for Sun Pharma's expansion.
Alembic Pharma gains after receiving USFDA tentative approval for Binimetinib tablets
Alembic Pharmaceuticals advanced 1.90% to Rs 764 after the company announced that it has received tentative approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Binimetinib Tablets, 45 mg.